Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!
FDA approves clinical trial on COVID-19 vaccine mix-and-match
FDA approves clinical trial on COVID-19 vaccine mix-and-match
ABS-CBN News
Published Nov 19, 2021 12:46 PM PHT
|
Updated Nov 19, 2021 12:57 PM PHT
A health worker show vials of the AstraZeneca COVID-19 vaccine at the Bakuna Bus (Vaccine Bus) by the Philippine Red Cross (PRC) in Manila on November 18, 2021. Jonathan Cellona, ABS-CBN News
MANILA— The Food and Drug Administration has approved the clinical trial on combining different COVID-19 vaccine brands for inoculation, an official said Friday.
The FDA approved the study on Tuesday and started screening applicants the next day at its trial site in Marikina, said Rowena Guevara, Department of Science and Technology Undersecretary for Research and Development.
Some 3,000 participants are needed in the clinical trial, Guevara said.
"Natapos na finally ang ating regulatory review ng mix and match at ang aplikasyon para sa clinical trial ay naaprubahan na ng FDA nung Nov. 16," she said in a virtual press briefing.
ADVERTISEMENT
(We've finished the regulatory review of mix and match and the application for clinical trial was approved by the FDA on Nov. 16.)
The rollout of booster shots for health care workers, which began Wednesday, will help in collecting data for the trial, Guevara added.
ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.
Our website is made possible by displaying online
advertisements to our visitors. Please consider supporting
us by disabling your ad blocker on our website.
Our website is made possible by displaying online
advertisements to our visitors. Please consider supporting
us by disabling your ad blocker on our website.
